David P. Bonita - Nov 22, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role: Director, 10%+ Owner
Signature: /s/ David Bonita
Stock symbol: TCDA
Transactions as of: Nov 22, 2022
Transactions value $: -$2,205,635
Form type: 4
Date filed: 11/25/2022, 07:08 PM
Previous filing: Oct 27, 2022
Next filing: Mar 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCDA	Common Stock	Sale	-$228K	-1.03M	-10.06%	$0.22^*	9.25M	Nov 22, 2022	See Footnotes	F1, F2, F3
transaction	TCDA	Common Stock	Sale	-$1.18M	-5.62M	-60.75%	$0.21^*	3.63M	Nov 23, 2022	See Footnotes	F2, F3
transaction	TCDA	Common Stock	Sale	-$798K	-3.63M	-100%	$0.22^*	0	Nov 25, 2022	See Footnotes	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average sale price of the shares of the Issuer's common stock ("Shares") sold, ranging from a low of $0.21 to a high of $0.22 per Share. The Reporting Person undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Shares sold at each separate price.
F2	The Shares are held of record by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("GP V") is the general partner of OPI V, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. The Reporting Person is a member of OrbiMed Advisors. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of the Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI V.
F3	Each of the Reporting Person, GP V, and OrbiMed Advisors disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his or its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, GP V, or OrbiMed Advisors is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.